Valensa International Awarded US Patent For EyePro MD

94439fc9-945c-4257-8ac5-66bb91402695articleimage.jpg

07 Jun 2017 --- Florida-based Valensa International has announced that it has received a US patent for its EyePro MD formula, which claims eye healthcare benefits related to its super-blend of lutein, zeaxanthin and astaxanthin mixed with omega 3 essential oils from krill, algae or perilla seed. The EyePro MD patented formulas feature the process of purifying the all-natural ingredients through extraction and stabilization using Valensa’s proprietary O2B peroxidation blocker technology and its Supercritical CO2 extraction technology.

Valensa International’s commercial formula includes a potent carotenoid portfolio, phospholipids and high ALA plant-derived omega 3 oils purified through Supercritical CO2 technology (also available with added krill or algae-based oils).

According to the company, the patent, titled “Eye Health Composition and Method using Plant-Derived Seed Extract Rich in Essential Fatty Acids Derived from Perilla Seed and Carotenoids,” outlines the health benefits this combination of all-natural, ingredients provides in EyePro MD. The formula delivers macular carotenoid supplementation, phospholipids for enhanced bioavailability and omega 3 essential fatty acids known to support heart and cognitive functions. Although the benefits of krill oil and algae oils are noteworthy, perilla seed oil offers a unique 6:1 ratio of ALA to LA or nearly twice the ratio found in flax seed oil.

“We have designed a small soft gel loaded with a potent combination of ingredients that can be absorbed efficiently to optimize eye health,” says Dr. John Minatelli, Senior Vice President of Business Development at Valensa. “Now with the patent IP in place, distributors and manufactures from the food and nutraceutical industry can include EyePro MD in their products knowing there’s nothing else like it on the market.” 

EyePro MD provides a potent array of carotenoids, which supports numerous eye health functions, according to the two-year, randomized study “The Carotenoid in Age-Related Maculopathy Italian Clinical Study” (CARMIS) in 2011. The carotenoid combination in EyePro MD was shown to reduce eye fatigue (Asthenopia) and contrast sensitivity. 

EyePro MD’s carotenoid portfolio is backed by additional science, including AREDS2, TOZAL and LAST studies as well as research conducted in Japan on astaxanthin for the treatment of eye fatigue, accommodation and protection from blue light damage.

The Japanese studies further confirmed that astaxanthin alone improved eye fatigue caused by blue light-induced oxidative stress (Digital Eye) in humans.  According to Dr. Minatelli, these studies also confirmed that astaxanthin is quickly incorporated into the eye’s vitreous humor where it acts as a potent blue light filter to protect the macular pigment degradation on the rod and cone surfaces. This allows the carotenoid portfolio to reduce oxidative stress to the associated retinal and macular cells thus protecting and supporting eye health. 

Stabilized Perilla seed oil reduces ocular inflammation by providing supplementation of ALA-based omega 3, an important pre-metabolite of EPA and DHA which are membrane-bound precursors of the potent anti-inflammatory prostaglandins. Seed oils rich in omega 3 content also support heart and cognitive health support.

According to the company, EyePro MD features a “powerful carotenoid combination and omega 3/phospholipid delivery system,” adding that it has a “zinc-free formula and is non-GMO, organic, no allergens, 100% vegetarian.”

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Advancing human health and nutrition: DSM on the key trends driving its R&D 

31 Jul 2018 --- Thriving in today’s business environment requires not only financial success, but hinges on an awareness of social responsibility, taking into account local and individualized preferences and needs as well as consumer education. This is according to Jeremy Xu, President Human Nutrition & Health at DSM, who spoke with NutritionInsight about the company’s focus on human health and nutrition as well as the key trends informing its innovation cycle.

Health & Nutrition News

Weekly Digest: Strategies to reduce kid’s sugary drink intake, Global krill companies pledge sustainable Antarctic harvesting

20 Jul 2018 --- In nutrition news this week, Croda Health Care became the first omega 3 fish oil supplier to achieve the five-star IFOS certification. A review highlighted the most successful strategies for reducing kid’s sugary drink consumption and the Mediterranean diet was found to improve adolescent’s academic performance. Eighty-five percent of global krill fishing companies have promised to fish more sustainably in the Antarctic ocean and Stepan Lipid Nutrition launched a newly designed website for its sports nutrition brand.

Health & Nutrition News

IFT 2018: Tate & Lyle on the prospects of its dietary fibers, instant starches and alternative proteins 

18 Jul 2018 --- At this year’s annual IFT Food Expo (15 to 18 July) in Chicago, Tate & Lyle is showcasing its collection of sweetener, enrichment and texturant ingredients. Focus areas are the company’s new instant starches, but also its portfolio of fibers, which were recently found to adhere to the US Food Drug Administration’s (FDA) definition of dietary fibers. NutritionInsight speaks with Mervyn L. de Souza, VP Health and Wellness at Tate & Lyle, about the company’s plans to expand its alternative proteins portfolio, as well as the benefits of its fiber ingredients.

Health & Nutrition News

Food for thought: Suppliers on the cognitive health ingredients market 

13 Jul 2018 --- Cognitive health has proven itself a growing category, with new products appealing to consumers from all walks of life, from more senior citizens seeking to prevent cognitive decline, to busy office workers looking to combat mental fatigue. NutritionInsight speaks to suppliers about their views on this growing category.

Packaging & Technology News

Weekly Digest: Valensa’s spirulina “first ever” to earn USP verification, study highlights how “exercise is medicine” for the gut

13 Jul 2018 --- In nutrition news this week, Valensa International’s Parry Organic Spirulina became the first to be awarded the United States Pharmacopeia (USP) verified mark. In research news, Sabinsa’s pterostilbene proved beneficial for diabetic animals, Nektium’s patent-pending botanical extract Zynamite gained clinical support and exercise was found to deliver gut-health benefits. B&D Nutritional Ingredients appointed a new US Northeast Sales Manager and Newtrition, BASF’s human nutrition brand is hosting a worldwide innovation challenge.

More Articles
URL : http://www.nutritioninsight.com:80/news/valensa-international-awarded-us-patent-for-eyepro-md.html